Project Narrative Type 1 diabetes is caused autoimmune destruction of the pancreatic beta-cells, but currently there is no therapy that can provide long-lasting improvements in beta-cell function. The aim of this project is to understand the mechanistic roles of two type 1 diabetes loci, CTSH and PGM1, in beta-cells. The proposed experiments will inform us whether these gene products could be targeted to enhance endogenous beta-cell function in type 1 diabetes.
|Effective start/end date||2/1/22 → 1/31/23|
- National Institute of Diabetes and Digestive and Kidney Diseases: $154,860.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.